Software as a Medical Device: Understanding, Regulations, and Security Priorities
How FDA defines and regulates SaMD, and what to prioritize in a SaMD security strategy.
Read articleFDA considers Software as a Medical Device a cyber device, whether it runs as a mobile app, in the cloud or as an AI-driven algorithm. Medcrypt helps SaMD teams close the gaps FDA reviewers flag.

Where SaMD cybersecurity gets hard
Cloud providers offer security tools, but configuring and maintaining a secure environment stays with the SaMD developer. FDA frequently identifies deficiencies in how cloud environments are secured.
FDA reviews highlight missing security testing: static and dynamic code analysis, fuzz testing, vulnerability scanning and penetration testing.
Common deficiencies include excluding relevant components and assuming the risks of interfaced devices are someone else's responsibility.
FDA mandates SBOMs for SaMD, documenting every software component. Continuous vulnerability monitoring and timely patching keep the device secure.
Cloud & APIsWhere the data and logic live
Web & mobile appsWhat users touch
Third-party componentsOpen source and SDKs
User dataPatient information in transit and at rest
Machine-readable SBOMs, vulnerabilities prioritized by exploitability, and FDA-ready SBOM, VEX and VDR exports.
SBOM managementConnect penetration testing to threat models, risk documentation, remediation and FDA submission evidence.
Penetration testingThreat models drafted from your architecture and checked for submission readiness by former FDA reviewers.
Threat modelingBenchmark your cybersecurity evidence against FDA eSTAR review categories before filing and find the gaps.
Clear FDA reviewKnow where your SaMD submission stands, starting with a 1‑hour review.
Threat model, SBOM, architecture views and testing, sized to your device.
Former FDA reviewers go through the package before you file.
If FDA sends questions, we typically turn around a full cybersecurity response in about 10 days.
How FDA defines and regulates SaMD, and what to prioritize in a SaMD security strategy.
Read articleCommon SaMD cybersecurity myths and how they show up as deficiencies in FDA reviews.
Read articleSection 524B applies to cyber devices: devices that include software validated, installed, or authorized by the manufacturer, have the ability to connect to the internet, and could be vulnerable to cybersecurity threats. The test is whether the device is capable of connecting, not only whether its intended use involves connecting. Because of the unique nature and high connectivity of SaMD, FDA considers SaMD to be cyber devices.
No. Cloud providers offer security tools, but the responsibility for configuring and maintaining secure environments lies with the SaMD developer. Best practices for cryptography, trusted communication and monitoring still apply, and FDA frequently identifies deficiencies in how cloud environments are secured.
A broad range of techniques: static and dynamic code analysis, fuzz testing, vulnerability scanning and penetration testing. FDA reviews highlight gaps in security testing and risk analysis, and regular audits and penetration testing find vulnerabilities before they can be exploited.